Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 176 active Chronic Lymphocytic Leukemia trials
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)
Study Type: Interventional Phase 2
CD22 Redirected Autologous T Cells for ALL
Study Type: Interventional Phase 1
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
Study Type: Interventional Phase 1
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter’s Transformation
Study Type: Interventional Phase 2
PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Study Type: Interventional Phase 2
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Study Type: Interventional Phase 1
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Study Type: Interventional Phase 2
There are 176 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now